Nachrichten zur Poolbeg Pharma PLC Aktie

FORM 8.5 (EPT/RI)…

NEW YORK and VIENNA, Austria, Feb. 20, 2025 (GLOBE NEWSWIRE) -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION…

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO…

Gilead Sciences Inc (NASDAQ:GILD, ETR:GIS), the largest shareholder in HOOKIPA Pharma, has thrown its backing behind the proposed merger with…

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO…

Jonathan Rowland increased his stake in fire suppression technology company Zenova Group (LON: ZED) to 7.8%. The share price rebounded…

Revolution Beauty (LON: REVB) has come to a confidential agreement with Chrysalis Investments (LON: CHRY) over the claims related to…

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO…

Poolbeg Pharma PLC (AIM:POLB) is already well down the path of establishing a rare disease company, said broker Shore Capital. “Lead…

Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) has been granted a full patent in the United States for its drug candidate POLB…

Poolbeg Pharma has revealed a substantial year of progress in which the well-capitalised biopharmaceuticals company made strides forward in the…

Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) has inked an exclusive 12-month option agreement to acquire a phase III-ready treatment from Silk Road...…

…

Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) said the US Patent Office has issued a Notice of Allowance for its immunomodulator II…